---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-019971"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2023-03-14T23:59:59+00:00"
generated_at: "2026-06-18T03:04:30.138313+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx announces $15M stock buyback program through March 2024

## Summary
- Board authorized repurchase of up to $15M of common stock.
- Program expires March 12, 2024 or when $15M of repurchases completed.
- Repurchases may be made in open market or privately negotiated transactions.
- Company plans to finance purchases using available cash and cash equivalents.

## SEC filing metadata
- accession: 0001213900-23-019971
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2023-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390023019971/0001213900-23-019971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390023019971/ea175219-8k_optimizerx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-019971
- JSON: https://secwatch.observer/filing/0001213900-23-019971.json
- Plain text: https://secwatch.observer/filing/0001213900-23-019971.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.